Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, Academy Award-winning documentarian Alex Gibney joins to talk about his latest work, a dissection of Theranos and Elizabeth Holmes, the company’s oft-discussed founder. Then we dig into a recent “60 Minutes” segment that underlines a roiling debate in the world of science. Biotech entrepreneur Ethan Perlstein stops by to explain the lessons he learned from a startup that went south. And, finally, we discuss the man chosen to replace Scott Gottlieb at the helm of the FDA.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy